Our study demonstrate that up-regulated leptin could stimulate proliferation and reduce the anti-tumor effect of chemotherapy in multiple myeloma possibly via activating AKT and STAT3 pathways, and leptin might be one of the potential therapeutic targets for treating myeloma. The gene discussed is LEP; the disease is AL amyloidosis.